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Introduction
Metabolic diseases such as obesity, insulin resistance, metabolic syndrome and type 2 diabetes (T2D) are reaching epidemic proportions. 1 Serious co-morbidities are associated with these conditions including hypertension, cardiovascular disease and increased risk for several types of cancer. 2, 3 Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of this group of disorders, increases the risk of hepatocellular carcinoma (HCC). 4 HCC is the 3 rd leading cause of cancer deaths worldwide, and the fastest rising cancer in the United States. 5 In a recent prospective study of asymptomatic U.S. middle-aged adults, the prevalence of NAFLD by ultrasound and/or biopsy was found to be 46%. 6 Nonalcoholic steatohepatitis (NASH), the more serious NAFLD subcategory defined by hepatic steatosis, inflammation and ballooning degeneration, afflicts 12% of middle-aged Americans. 6 As a result, NAFLD/NASH may one day surpass hepatitis C virus infection as the leading cause of HCC in this country.
Genetic predisposition contributes to HCC risk on a metabolic background, but molecular markers of preneoplastic progression and hepatocellular transformation remain elusive.
Moreover, due to extensive overlap in clinical presentation, it is difficult to ascribe hepatic consequences such as NAFLD and HCC to specific metabolic triggers. Existing animal models of metabolic hepatopathy are ill-equipped to address these questions because most exhibit obesity, insulin resistance and/or T2D as part of a disease continuum. New models are needed to dissect the roles of individual metabolic parameters in the pathogenesis of hepatic steatosis and carcinogenesis. Here, we report a novel mouse model of primary insulin resistance and NAFLD leading to HCC in the absence of obesity or T2D. Intriguingly, the model exhibits strong parentof-origin effects encoded predominantly within the somatic genome, suggesting involvement of imprinted genetic elements that may serve as useful biomarkers and/or interventional targets. We used this model to probe mechanisms of hyperinsulinemic NAFLD and HCC, and documented adipogenic transition of hepatocytes with reactivation of the anabolic enzyme pyruvate kinase M2, a fetal proto-oncogene associated with the Warburg Effect. 7 Taken together, our results suggest that epistatic interactions between parent-specific loci play an important role in regulating insulin sensitivity, and that hepatocellular adipogenic transition with acquired anabolic metabolism represents a potential mechanistic link between NAFLD and HCC.
Materials and Methods

Animals and Study Design
A/JCr mice (A/J) were purchased from the National Cancer Institute (Frederick, MD). C57BL/6J (B6) and B6.A chromosome substitution-strain (CSS; consomic) mice were obtained from the Jackson Laboratory (Bar Harbor, ME). Experiments were performed in facilities accredited by the Association for Assessment and Accreditation of Laboratory Animal Care. Mice were maintained in static microisolator cages under specific pathogen-free conditions for 11 murine viruses, Helicobacter spp., Salmonella spp., Citrobacter rodentium, ectoparasites and endoparasites. Helicobacter-free status was confirmed by DNA PCR on pooled cage feces. 8 In the first experiment, A/J and B6 mice were intercrossed and parent-of-origin records maintained to identify offspring as AB6F1 or B6AF1. All F1 offspring (n=59) were fed the same rodent chow diet (Prolab RMH 3000; Scott's Distributing, Hudson, NH) and collected at 3, 9 or 15 months of age. In a follow-up diet-induced obesity (DIO) study, A/J, C57BL/6J-Chr X A/J /NaJ (B6.AX), C57BL/6J-Chr Y A/J /NaJ (B6.AY), AB6F1 and B6AF1 mice were raised under standard conditions until 6 weeks of age and then randomly assigned into low-fat (LF) or high- Blood and tissue analyses Blood glucose concentrations were obtained using the One Touch Basic glucometer (LifeScan, Milpitas, CA). Cholesterol was measured with the Accutrend GC (Roche Diagnostics, Branchburg, NJ). Serum insulin was determined with the Lincoplex rat/mouse insulin ELISA kit (Millipore, Billerica, MA). The homeostatic model of assessment for insulin resistance (HOMA-IR) was calculated as described. 10 Parametric laboratory data between all groups were compared by one-way analysis of variance (ANOVA) with Tukey post-test, and between pairs by Student t-test using Prism software (GraphPad, San Diego, CA). P-values < 0.05 were considered significant. Hematoxylin and eosin-stained slides of liver were graded by a board-certified veterinary pathologist (A.B.R.) blinded to sample identity for hepatic steatosis based on semiquantitative percentage of centrilobular and midzonal hepatocytes containing lipid vacuoles: (0) < 5% of hepatocytes, (1) 5-25%, (2) 25-50%, (3) 50-75%, (4) >75%. Macrovesicular and microvesicular steatosis were scored separately according to published morphologic criteria. The combined scores were added to generate a fatty liver index. Inflammation and dysplasia/neoplasia also were scored according to our published criteria. 9 Nonparametric histopathology scores were compared between all groups by Kruskal-Wallis ANOVA with Dunn's post-test, and between pairs by Mann Whitney-U. Frozen liver sections in O.C.T. medium were cryosectioned and stained with oil red O for lipids. Immunohistochemistry for PKM2 (antibody #3198, Cell Signaling Technology, Beverly, MA) was performed on a Bond-III immunostainer (Leica, Bannockburn, IL) following techniques we have published. 11 Gene expression analysis mRNA was isolated from liver and assessed for quality as we have previously described. 12 Tissues from two 9-month-old male AB6F1 and B6AF1 mice were analyzed using the Mouse Genome 430A 2.0 Array (Affymetrix, Santa Clara, CA). Data were imported into Partek Genomics Suite (Partek, St. Louis, MO) using Robust Multichip Average, and normalized by response variable. Data were filtered by presence/absence call and P-value (<0.05). Signal foldchanges ≥1.5 were considered significant. The complete data set was deposited in the NIH Gene Expression Omnibus, #GSE26225. Results for selected genes were validated and extended across all groups by SYBR green quantitative RT-PCR (qRT-PCR) as described previously. 13 Primers were designed using MacVector 11 software (Cary, NC). Unique primer sequences are presented in Table 1 ; all others as described by Amador-Noguez et al. 14 
Primary hepatocyte isolation and culture
Primary mouse hepatocytes were derived from collagenase-digested 8-week-old male B6 mouse livers, and isolated and cultured following protocols described elsewhere with minor modification. 15 Briefly, murine livers were sequentially perfused in situ with 25 mL calcium-free EGTA-containing buffer followed by 50 mL buffered saline containing 0.3 mg/mL Type IV collagenase (Roche Diagnostics Corp, Indianapolis, IN) at 37 o C. Following perfusion, collagenase-treated livers were dissociated by mincing with scissors followed by passage through a 100 µm-pore nylon mesh. Hepatocytes were purified via repeated (3X) low-speed (50 x g) centrifugation. Cell purity was assessed by light microscopy and by fluorescence-assisted cell sorting. For the latter, 1x10 5 cells were labeled with anti-CD45/leukocyte-common antigen or anti-Fas (CD95) antibodies (or appropriate conjugated isotype control antibodies, all from eBioscience, San Diego, CA) for 30 minutes at room temperature followed by evaluation on an Accuri C6 Flow Cytometer (Ann Arbor, MI). Purified hepatocytes were grown on collagen Icoated matrices (BD Biocoat, BD Biosciences, Franklin Lakes, NJ) in Dulbecco's modified Eagle medium with 10% fetal bovine serum, penicillin/streptomycin, and 2 mM L-glutamine.
Subsets of cells were supplemented with insulin (5 mg/L), transferrin and selenium (ITS) ± dexamethasone (10 mM; both Sigma, St. Louis, MO). After 1 or 4 days, cells were harvested and RNA isolated followed by qRT-PCR as described above. Cell viability was determined using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) kit according to the manufacturer's instructions (Molecular Probes, Eugene, OR). For assessment of hepatocyte morphology, cell suspensions were dropped onto silanized glass slides, fixed in chilled acetone for 10 min, and stained with Diff-Quik (Fisher Scientific, Pittsburgh, PA).
Results
Insulin resistance without obesity or T2D in AB6F1 male mice
We characterized the phenotype of AxB F1 mice fed a standard rodent chow diet for 3, 9 or 15 months. First, body and liver weights were determined. AB6F1 male mice weighed 15-23% more than age-matched B6AF1 controls when compared across time points ( Fig. 1 ). Whereas this difference was statistically significant, AB6F1 mice were not obese and could not be visually distinguished from BA6F1 males. Female AB6F1 mice also weighed slightly more than B6AF1 females, but the difference was statistically insignificant (not shown). AxB F1 mice of both sexes weighed more than published mean body weights for either parental inbred strain (Mouse Phenome Database, Jackson Laboratory). Thus, hybrid mice were larger than parental strains, but morbid obesity was not a component of the F1 phenotype. At necropsy, it was noted that the livers of many males were enlarged and pale. Absolute liver weight and liver:body weight ratios were found to be greater in AB6F1 than B6AF1 male mice at 9 and 15 months ( Fig. 1 ). Male AB6F1 had significantly increased serum insulin levels relative to B6AF1 males at all time points. Nevertheless, despite increased serum insulin levels in AB6F1 males there were no significant differences in mean blood glucose between any groups regardless of sex or time point (not shown). Moreover, no animals developed polyuria, polydipsia, hyperphagia and/or body wasting characteristic of diabetes. 16 Thus, in spite of high circulating insulin levels, AB6F1 mice did not exhibit obesity or T2D. These results demonstrate that AB6F1 but not B6AF1 male mice develop spontaneous hyperinsulinemia on a standard chow diet, and that this insulin resistance is not associated with morbid obesity, metabolic syndrome or T2D.
Hyperinsulinemic NAFLD and HCC in AB6F1 males
Blinded histopathologic assessment of livers from AxB F1 mice revealed mild-to-moderate hepatic steatosis in a subset of animals by 3 months of age, marked steatosis by 9 months, and severe steatosis with dysplasia and/or HCC by 15 months. When the results were decoded, it was confirmed that the most significant lesions arose in hyperinsulinemic AB6F1 males ( Fig. 2A ). B6AF1 males showed no or minimal liver lesions at 3 and 9 months of age. However, 50% of BA6F1 males did exhibit mild-to-moderate steatosis at 15 months. In AB6F1 males, histologic changes characteristic of insulin resistance were identified in tissues besides the liver as well.
These included WAT degeneration with F4/80 + pericellular macrophages forming crown-like rosettes, thoracic BAT metaplasia to a WAT phenotype, focal skeletal muscle degeneration with fatty replacement, and pancreatic islet hyperplasia with occasional megaislets (Fig. 2B ). Within the liver, preneoplastic and neoplastic lesions including foci of cellular alteration, dysplastic nodules and HCC were limited to AB6F1 males (30% incidence versus 0% in BA6F1; Fig. 2C ). This is significant because spontaneous HCC is very rare in wild-type (WT) A/J and B6 strains within the typical 24-month lifespan (Mouse Phenome Database). Because high insulin levels also have been associated with tumors of the pancreas and lower bowel, 17, 18 we examined those organs grossly and histologically but found no neoplastic or preneoplastic lesions (not shown).
Histopathology of female mouse tissues including liver was unremarkable. These findings are consistent with the male-predominance of metabolic and neoplastic liver disease documented in humans and other rodent models. 6, 19 Viewed together these results demonstrate that hyperinsulinemia, in the absence of morbid obesity, metabolic syndrome or T2D, is sufficient to induce HCC in mice.
NAFLD-associated cytokine induction, acute-phase responses and hepatic feminization
To determine the global impact of hepatic steatosis on gene expression, we performed microarray analysis of liver samples from 9-month-old male AB6F1 and B6AF1 mice.
Hierarchal clustering analysis using Partek Genomics Suite demonstrated clear segregation of the two genotypes ( Fig. 2D ). Four interrelated pathophysiologic processes were evident in the steatotic male AB6F1 liver: inflammation, acute-phase responses (APR), transcriptional feminization, and metabolic derangement. Numerous proinflammatory genes were upregulated including Stat1, IFN-γ-induced GTPases and interferon-activated/regulatory factors, histocompatibility 2 class II antigens, and others (top 10 altered genes Table 2 ; complete data set available Gene Expression Omnibus #GSE26225). APR induction was confirmed by the upregulation of canonical acute-phase murine genes including lipocalin 2, serum amyloid A1 and A2, orosomucoid, and metallothioneins 1 and 2. 12 Of note, all of these transcriptional changes occurred in the absence of histologic hepatitis, demonstrating that NAFLD produces a morphologically covert pro-inflammatory microenvironment. Nonspecific injury of the male mouse liver frequently leads to loss of gender-specific gene expression characterized by transcriptional feminization. 13 Accordingly, we found a significant bias for sex-dependent gene alterations in the feminine direction in AB6F1 males with NAFLD. Feminine genes up-regulated in the steatotic male liver included sulfotransferase 2a2 and Sult3a1, cytochrome P450 2b13 (Cyp2b13), lymphocyte antigen 6 complex locus D, ATP-binding cassette D2, fatty acid-binding protein 5 (epidermal), and acyl-CoA thioesterase 3. Simultaneously, masculine genes were downregulated in the male AB6F1 liver including solute carrier organic anion transporter 1a1, hydroxysteroid dehydrogenase 3β-V, elongation of very long chain fatty acids-like 3, elastase-1 (pancreatic), and Cyp7b1. Whereas many of the metabolic gene alterations in AB6F1 male mice were attributable to hepatic feminization, gender-neutral genes associated with metabolic function also were dysregulated including potassium channel T2, complement factor D (adipsin), sulfotransferase 5A1, and insulin-like growth factor binding protein 2. Taken together, these data demonstrate that insulin resistance and NAFLD are sufficient to invoke robust hepatic transcriptional alterations related to inflammation, metabolism and sex-dependent liver function.
Parent-of-origin effects not linked to known maternal/paternal genes There are three known sources of parent-specific gene expression: mitochondrial DNA, imprinted loci, and sex-linked genes. 20 Genes transcribed from mitochondrial DNA are maternal in origin, imprinted genes are transcribed from a single parental allele, and sex chromosomes are inherited in parent-specific fashion in males. Because of the strong parent-of-origin effects in AxB F1 mice, we interrogated by qRT-PCR genes meeting any of those criteria and shown to be differentially expressed by microarray. Additionally, we analyzed known parent-specific genes canonically associated with metabolism. Altogether, we assessed 4 mitochondrial DNA transcripts, 8 imprinted alleles, and 29 sex-linked genes in all male mice (Table 1) . No imprinted or mitochondrially-encoded gene exhibited differential expression between AB6F1 and B6AF1 mice (data not shown). In contrast, four X-linked genes showed a positive correlation with NAFLD at one or more time points. Of these, three were upregulated at 9 and 15 months only (Frmpd3, Slc25a5, Tmsb4x), suggesting an associative rather than causative relationship. The only X-linked gene upregulated at all time points in AB6F1 males was thyroxine-binding globulin (TBG; Serpina7). Interestingly, this gene also was increased in B6AF1 males with steatosis at 15 months. However, in all affected animals TBG upregulation was modest (~2-fold) and showed no linear correlation with NAFLD severity (data not shown). Further work will be required to determine whether TBG contributes to the pathogenesis of insulin resistance and NAFLD or is merely a bystander. Viewed as a whole, our PCR survey failed to identify a robust candidate among known uniparentally expressed genes to account for the dramatic parentspecific metabolic phenotype in AxB F1 males, suggesting that the disease is polyfactorial and may involve epigenetic mechanisms.
Gender-and strain-specific responses to high-fat diet in CSS and F1 mice Because we found some associations between X-linked genes and the AB6F1 metabolic phenotype, we performed a follow-up DIO study using sex chromosome-substitution strain B6.A mice. These animals were on a B6 background except for an A/J-derived sex chromosome. 21 Also included were AxB F1 mice along with a WT A/J control group. An additional control group of WT B6 mice had to be excluded due to poor breeding kinetics resulting in insufficient numbers. In agreement with the first study showing increased BW in AxB F1 mice relative to the parent strains, B6AF1 and AB6F1 mice on the LF diet weighed significantly more than sexmatched A/J and CSS strains ( Table 3 ). All mice on the HF diet weighed significantly more than sex-and strain-matched animals on the LF diet. However, as a percentage of baseline body mass, CSS mice on the HF diet gained more weight than A/J and F1 mice. This was especially true of B6.AX males, which weighed less than all other male groups on the LF diet, but the same as all but the A/J males on the HF diet. In A/J and CSS mice, serum insulin levels rose in relative proportion to body mass on the HF diet. In stark contrast, insulin levels were significantly lower in B6AF1 and significantly higher in AB6F1 males compared with CSS mice despite nearly identical body weights (Fig. 3) . A similar dichotomy between serum insulin and body mass was observed in female F1 mice on the HF diet. Thus, insulin resistance in F1 mice was regulated by distinct mechanisms from those governing diet-induced weight gain. Female CSS and AxB F1 but not A/J mice on the HF diet exhibited mild-to-moderate macrovesicular steatosis that did not vary by strain (data not shown). Male A/J mice on the HF diet developed moderate patchy macrovesicular steatosis, whereas CSS and F1 males developed severe diffuse mixed hepatic steatosis (mean fatty liver index = 5/8; not shown). The proportion of microvesicular-tomacrovesicular steatosis varied within but not between groups. Viewed as a whole, these results demonstrated that weight gain and hepatic steatosis increased in tandem in response to the HF diet, whereas insulin resistance was distinctly regulated in F1 male and female mice. Indeed, B6AF1 were protected from DIO-associated insulin resistance compared with CSS mice, whereas AB6F1 displayed exaggerated hyperinsulinemia in response to caloric overload. This suggests synergy in epistatic interactions between parent-specific alleles in hybrid mice resulting in a marked shift in insulin sensitivity in a positive or negative direction. Taken together, these results show that insulin resistance is not directly correlated with increased body mass, and that additional genetic factors determine the metabolic consequences of diet-induced obesity.
Insulin resistance invoked adipogenic transition of hepatocytes and reactivated PKM2
Because of the remarkable histologic similarity between steatotic hepatocytes and adipocytes ( Fig. 2E) , we wondered whether fatty liver was associated with molecular changes characteristic of adipogenic transition. 22 By microarray and qRT-PCR, we found numerous examples of adipocyte-associated genes that were upregulated in the livers of 9-month-old AB6F1 mice with NAFLD compared with B6AF1 controls. As mesenchymal cells, adipocytes express a number of canonical genes not typically expressed in hepatocytes and other epithelial tissues. Mesenchymal cell markers that were increased in the livers of mice with NAFLD included vimentin, plateletderived growth factor-β, and collagen 3α-1 ( Fig. 4A and Supplemental Data). Additionally, there was upregulation of more specific adipocyte-associated genes including complement factor D (adipsin), fatty acid translocase (CD36), fatty acid binding protein-4 (adipocyte), and peroxisome proliferator-activated receptor-γ (PPARγ). Of singular importance, the fetal isoform of pyruvate kinase, Pkm2 was upregulated nearly 2-fold in 9-month-old mice with NAFLD. Functional protein expression was confirmed by IHC, where cytoplasmic and nuclear PKM2 localization was visualized in neoplasms from AB6F1 mice, but not in normal B6AF1 liver ( Fig. 2A) . These results confirm that chronic hyperinsulinemia invokes adipogenic transition of hepatocytes and invokes metabolic pathways in improper context that may contribute to cellular transformation.
Insulin-dependent adipogenic transition and PKM2 activation in cultured hepatocytes
To validate our in vivo findings and confirm that transcriptional alterations reflected changes in parenchymal and not accessory liver cells, we harvested, purified and cultured primary mouse hepatocytes. To insure purity, we performed FACS analysis which confirmed <2% contamination by white blood cells (Fig. 4A ). Approximately 25% of the purified hepatocytes were positively labeled with an anti-CD95/Fas antibody, in keeping with the known low level of Fas surface expression in healthy mouse liver. 23 To insure that our cultured cell population was primarily hepatocytes, we performed qRT-PCR for albumin and Apoa1 on freshly purified cells and found gene expression levels similar to those from intact mouse liver RNA (not shown).
Primary hepatocytes grown in the presence of insulin exhibited greater viability after 4 days than did those grown without insulin supplementation (Fig. 4B ). Under all growth conditions, primary hepatocytes organized into crude canalicular structures; however, insulin-supplemented cells exhibited clear cytoplasmic lipid-storage vacuoles that were not evident in cells grown in the presence of dexamethasone alone (Fig. 4B) . Insulin supplementation to primary hepatocytes resulted in upregulation of many of the same adipocyte-associated genes we documented in AB6F1 mice with NAFLD, including but not limited to vimentin, collagen 3α-1, fatty acid translocase (CD36) and Pkm2 (Fig. 4C ). Taken together, these results confirm that supraphysiologic levels of insulin promote hepatocyte survival and invoke activation of adipocyte-associated metabolic pathways that may contribute to cellular transformation.
Discussion
Beneath the current wave of obesity and T2D lurks a larger swell of subclinical metabolic disease. In some settings, up to 75% of individuals with NAFLD are nonobese. 24 Most diagnoses of NAFLD in the United States are made in patients without previously identified risk factors.
Indeed, in a recent study, nearly half of clinically healthy middle-aged adults in the U.S. exhibited NAFLD by ultrasound and/or biopsy. 6 The potential impact of covert insulin resistance and NAFLD on a national scale is unknown. However, it is noteworthy that HCC continues to rise in the United States despite flat or declining levels of viral hepatitis and alcoholism. Indeed, NAFLD/NASH may one day surpass HCV infection as the leading cause of liver cancer in the United States. 5
Because of the complex interactions between metabolic disease and HCC, animal models are needed to characterize the molecular events leading from steatosis to cancer. We observed that male F1 offspring of A/J and B6 mice developed spontaneous insulin resistance, NAFLD and HCC without obesity or T2D. Intriguingly, the model exhibited strong parent-of-origin effects.
AB6F1 but not B6AF1 mice developed early onset insulin resistance and NAFLD that progressed to HCC in many by 15 months of age. Despite this parent-of-origin-specific inheritance, we found no strong associations with known uniparentally expressed mitochondrial or imprinted genes, although modest associations with some X-linked genes were suggested.
However, a follow-up DIO study involving X and Y CSS mice confirmed no significant phenotypic segregation by sex chromosome, although B6.AX mice did exhibit a leaner metabolic profile than B6.AY mice on the LF diet. We concluded that the strong parent-of-origin effects in AxB F1 mice were specified within the somatic genome. Importantly, the DIO experiment also revealed that obesity and insulin resistance were regulated by distinct genetic mechanisms in hybrid animals.
Diabetes is associated with increased risk of HCC in humans. 25 In diabetic patients, treatment with sulphonylurea or exogenous insulin increases HCC risk and worsens tumor response to radioablation, whereas HCC patients taking the insulin-sensitizing drug metformin have more favorable outcomes. [26] [27] [28] This suggests a direct role for insulin in liver tumor promotion. Because insulin resistance in the absence of obesity or diabetes was sufficient to promote HCC in AB6F1 mice, we investigated potential mechanisms of metabolic hepatocarcinogenesis. In mice with hyperinsulinemic NAFLD, hepatocytes underwent partial adipogenic transition characterized morphologically by vacuolar metaplasia resembling WAT or BAT. At the molecular level, canonical adipocyte genes were activated in steatotic hepatocytes including vimentin, adipsin, fatty acid translocase (CD36), fatty acid-binding protein 4 (adipocyte), stearoyl-coA desaturase 2, and PPAR-γ. This transcriptional profile was largely recapitulated in insulin-supplemented, but not deprived, primary mouse hepatocytes in vitro. Supraphysiologic insulin exposure also promoted hepatocyte survival in culture. Of special significance discussed below, we found that excess insulin reactivated the fetal isoform of pyruvate kinase (PKM2) in hepatocytes both in vitro and in vivo.
Complex metabolic traits are regulated polygenetically. 29 Thus, our inability to pinpoint a single gene that accounted for the parent-specific metabolic phenotype in AxB F1 mice was not surprising. Because neither parental inbred strain develops equivalent disease, polygenetic crosstalk rather than a single gene polymorphism best explains the positive and negative heterosis observed in B6AF1 and AB6F1 males, respectively. 30 Whereas our genomic survey of F1 mice did reveal a modest association between NAFLD and X-linked thyroxine-binding globulin, the follow-up DIO study with CSS mice did not validate phenotypic segregation by sex chromosome. In the original description of B6.A CSS mice, it was noted that 17 of the 23 CSS lines exhibited an intermediate obesity phenotype between parental inbred strains. 21 Thus, metabolism is governed by multiple genes on an array of different chromosomes. Recent work has revealed important obesity-related quantitative trait loci on chromosomes 6 and 17. 31, 32 Others are likely to follow. Combining our results with those from other laboratories, it seems clear that polygenic epistatic interactions including those inherited in a parent-specific fashion coordinately regulate insulin sensitivity. These findings take on direct translational significance in light of a recent study from Iceland showing that parent-specific somatic polymorphisms strongly influence T2D risk in humans. 33 In addition to its value as a genetic tool, the AxB mouse model has utility for addressing molecular mechanisms of hepatocarcinogenesis in the context of primary insulin resistance. For example, we observed that vacuolated hepatocytes in mice with hyperinsulinemic NAFLD not only took on a morphologic appearance of WAT or BAT, but also expressed many genes classically associated with adipose tissue. These included but were not limited to adipsin, fatty acid translocase, fatty acid binding-protein 4, vimentin and PPARγ. The important role of insulin in adipogenic transition was confirmed by our in vitro experiments that recapitulated the emergence of lipid vacuoles along with up-regulation of adipogenic genes in primary mouse hepatocytes. Moreover, we confirmed that insulin extends hepatocyte survival and inhibits apoptosis. This may have in vivo significance, as liver cells undergoing severe oxidative stress in a pro-inflammatory microenvironment would be prevented from entering apoptosis in the context of hypersinulinemia, as shown experimentally in skeletal muscle. 34 A singularly important potential link between hyperinsulinemia, adipogenic transition and HCC revealed by this study was pyruvate kinase M2. Pyruvate kinases are critical enzymes in glycolytic oxidative phosphorylation. There are four pyruvate kinase isoforms: L, R, M1 and M2. 35 The adult liver is characterized by expression of the L-type isoform. 36 In contrast, M2 is expressed predominantly during embryogenesis in the fetal liver and other rapidly dividing tissues. 37 In contrast to the adult isoforms, PKM2 diverts glucose metabolism to an alternate pathway that generates short carbon chains for molecular building blocks needed by rapidly dividing cells. 38 Aberrant expression of PKM2 is a common feature of cancers that rely on aerobic gycolysis with lactate generation (Warburg Effect) to support rapid proliferation.
Intriguingly, PKM2 is activated normally in an insulin-dependent fashion during the programmed differentiation of NIH 3T3 cells from preadipocytes to adipocytes. 39 It is possible that insulin invokes adipogenic transition and Pkm2 expression in hepatocytes through similar mechanisms. Of note, the only two adult mammalian tissues that ordinarily express PKM2 are skeletal muscle and adipose tissue, both of which are replicatively senescent. 40, 41 In contrast, hepatocytes enter cell division with little prompting. It is tempting to speculate that insulindirected PKM2 reactivation in replication-competent cells such as hepatocytes represents a significant proto-oncogenic event. If so, PKM2 inhibitors currently under development for the treatment of established cancer also may have utility for the prevention of HCC in patients with insulin resistance and NAFLD. 42 Further study will be required to test this hypothesis.
In summary, we have introduced a novel mouse model of primary insulin resistance, NAFLD and HCC with strong parent-of-origin effects. AB6F1 but not B6AF1 male mice develop spontaneous insulin resistance that leads to severe NAFLD by 9 months and HCC by 15 months.
Parent-specific inheritance in this model is polygenetic and encoded within the somatic genome.
We have shown that insulin resistance is regulated independently of diet-induced weight gain in Among the adipocyte-associated genes in this program is PKM2, an anabolic enzyme implicated in tumorigenesis and the Warburg Effect. Viewed as a whole, our study implicates the existence of somatic parent-specific loci that may serve as useful biomarkers for metabolic risk profiling, and identifies new potential targets to improve insulin sensitivity and prevent NAFLD-associated HCC. non-supplemented cells (light gray columns); these genes also were upregulated in AB6F1 versus B6AF1 male mice at 15 months of age (black columns).
